Alcon AG | ALC - Cost Of Sales


Alcon AG reported $1.12B in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
AstraZeneca USD 2.52B 2.73B Jun/2026
Bayer EUR 4.54B 692M Jun/2026
Essilor EUR 5.55B 505M Jun/2026
Fresenius EUR 4.4B 111M Jun/2026
Fresenius Medical Care EUR 3.55B 117.58M Jun/2026
GlaxoSmithKline GBP 2.07B 192M Jun/2026
GRIFOLS EUR 1.17B 90M Jun/2026
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.27B 199M Jun/2026
Novartis USD 3.71B 251M Jun/2026
Philips EUR 2.21B 70M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
Sanofi EUR 3.02B 656M Jun/2026
Smith & Nephew USD 901M 31M Jun/2026
Sonova Holding CHF 539.4M 11.5M Dec/2025
UCB EUR 1.07B 146M Dec/2025